Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Umesh U Tamhane"'
Autor:
Krishna G Aragam, Umesh U Tamhane, Eva Kline-Rogers, Jin Li, Keith A A Fox, Shaun G Goodman, Kim A Eagle, Hitinder S Gurm
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e7947 (2009)
BackgroundThe Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk
Externí odkaz:
https://doaj.org/article/51b3d8bcbf0947bca907f131dcf90b65
Autor:
Kelly Gordon, James B. Froehlich, Vijay S. Ramanath, David F. Armstrong, Umesh U. Tamhane, Elizabeth A. Jackson, Mary Grzybowski, Sahand Rahnama-Mohagdam, Kim A. Eagle
Publikováno v:
Clinical Cardiology. 33:36-41
Management of acute coronary syndrome (ACS) patients with nonobstructive epicardial coronary artery disease (CAD) remains poorly understood.Acute coronary syndrome patients with nonobstructive CAD are less likely to receive effective cardiac medicati
Autor:
Umesh U. Tamhane, Pascal Meier, Hitinder S. Gurm, Kang Yin Chen, Seung-Woon Rha, Stanley Chetcuti, Michael P. Grossman
Publikováno v:
EuroIntervention. 5:384-393
Aims: Cilostazol has been associated with reduction in restenosis in patients undergoing coronary and peripheral arterial angioplasty. Our objective was to evaluate the impact of cilostazol on restenosis in patients undergoing contemporary PCI with b
Autor:
Hitinder S. Gurm, Umesh U. Tamhane, Pascal Meier, Kathy Welch, Michael C. Reed, Mauro Moscucci
Publikováno v:
JACC: Cardiovascular Interventions. 2(7):645-654
Objectives We sought to compare the nephrotoxicity of the iso-osmolar contrast medium, iodixanol, to low-osmolar contrast media (LOCM). Background Contrast-induced acute kidney injury (CI-AKI) is a common cause of in-hospital renal failure. A prior m
Autor:
Umesh U. Tamhane, Hitinder S. Gurm
Publikováno v:
Expert Opinion on Drug Safety. 7:809-819
Abciximab is a monoclonal antibody that prevents platelet aggregation by blocking platelet glycoprotein (GP) IIb/IIIa receptor.To study the safety profile of this agent in contemporary clinical practice.We evaluated efficacy and safety end points (ma
Autor:
Umesh U. Tamhane, Hitinder S. Gurm
Publikováno v:
Current Cardiology Reports. 10:424-430
Primary percutaneous coronary intervention (PCI) with adjunctive glycoprotein (GP) IIb/IIIa receptor inhibitor therapy administered in the cardiac catheterization laboratory is the optimal reperfusion strategy for patients with ST-elevation myocardia
Autor:
Umesh U. Tamhane, Apurva A. Motivala, Eva Kline Rogers, Kim A. Eagle, Mauro Moscucci, Jin Li, Hitinder S. Gurm, James B. Froehlich, Fadi Saab
Publikováno v:
The American Journal of Cardiology. 100:1359-1363
Antithrombotic and antiplatelet agents are essential for the management of patients with acute coronary syndromes (ACSs). These pharmacologic agents have the potential for increased risk of bleeding. It is not clear if the increased uptake of these t
Autor:
Pascal Meier, P. Michael Grossman, Stanley Chetcuti, Hitinder S. Gurm, Eric R. Bates, Umesh U. Tamhane
Publikováno v:
Circulation. Cardiovascular interventions. 2(3)
Background— Current guidelines recommend abciximab as the preferred agent for patients undergoing primary percutaneous coronary intervention, yet small-molecule glycoprotein IIb/IIIa inhibitors are more commonly used in clinical practice. The objec
Autor:
Keith A.A. Fox, Umesh U. Tamhane, Hitinder S. Gurm, Jin Li, Shaun G. Goodman, Kim A. Eagle, Krishna G. Aragam, Eva Kline-Rogers
Publikováno v:
Aragam, K G, Tamhane, U U, Kline-Rogers, E, Li, J, Fox, K A A, Goodman, S G, Eagle, K A & Gurm, H S 2009, ' Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores ', PLoS ONE, vol. 4, no. 11, e7947 . https://doi.org/10.1371/journal.pone.0007947
PLoS ONE
PLoS ONE, Vol 4, Iss 11, p e7947 (2009)
PLoS ONE
PLoS ONE, Vol 4, Iss 11, p e7947 (2009)
BackgroundThe Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71cc906839ccc762ed06c1563082b55e
https://www.pure.ed.ac.uk/ws/files/8138416/Does_simplicity_compromise_accuracy_in_ACS_risk_prediction.pdf
https://www.pure.ed.ac.uk/ws/files/8138416/Does_simplicity_compromise_accuracy_in_ACS_risk_prediction.pdf
Autor:
Michael, Reed, Pascal, Meier, Umesh U, Tamhane, Kathy B, Welch, Mauro, Moscucci, Hitinder S, Gurm
Publikováno v:
JACC. Cardiovascular interventions. 2(7)
We sought to compare the nephrotoxicity of the iso-osmolar contrast medium, iodixanol, to low-osmolar contrast media (LOCM).Contrast-induced acute kidney injury (CI-AKI) is a common cause of in-hospital renal failure. A prior meta-analysis suggested